These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12383389)

  • 21. Which drugs benefit diabetic patients for secondary prevention of myocardial infarction? DARTS/MEMO Collaboration.
    MacDonald TM; Butler R; Newton RW; Morris AD
    Diabet Med; 1998 Apr; 15(4):282-9. PubMed ID: 9585392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of acute coronary syndromes.
    Schulman SP; Fessler HE
    Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971
    [No Abstract]   [Full Text] [Related]  

  • 23. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
    Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival.
    Weightman WM; Gibbs NM; Sheminant MR; Whitford EG; Mahon BD; Newman MA
    Anesth Analg; 1999 Feb; 88(2):286-91. PubMed ID: 9972742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence supporting secondary prevention strategies.
    Blazing MA; O'Connor CM
    Curr Opin Cardiol; 1999 Jul; 14(4):303-9. PubMed ID: 10448610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary prevention in coronary heart disease: goal achievement and drug prescribing.
    Giverhaug T; Bruland C; Trovik T
    Pharm World Sci; 2005 Dec; 27(6):472-4. PubMed ID: 16341957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D; Unal B; Critchley J; Capewell S
    QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term adherence with cardiovascular drug regimens.
    Kulkarni SP; Alexander KP; Lytle B; Heiss G; Peterson ED
    Am Heart J; 2006 Jan; 151(1):185-91. PubMed ID: 16368315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.
    Komajda M; Follath F; Swedberg K; Cleland J; Aguilar JC; Cohen-Solal A; Dietz R; Gavazzi A; Van Gilst WH; Hobbs R; Korewicki J; Madeira HC; Moiseyev VS; Preda I; Widimsky J; Freemantle N; Eastaugh J; Mason J;
    Eur Heart J; 2003 Mar; 24(5):464-74. PubMed ID: 12633547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
    Griffiths B; Lesosky M; Ntsekhe M
    S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues.
    Underwood P; Beck P
    Qual Saf Health Care; 2002 Sep; 11(3):230-2. PubMed ID: 12486986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of an educational program on the prevalence of use of antiplatelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease.
    Sanal S; Aronow WS
    J Gerontol A Biol Sci Med Sci; 2003 Nov; 58(11):1046-8. PubMed ID: 14630888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period.
    Martínez M; Agustí A; Arnau JM; Vidal X; Laporte JR
    Eur J Clin Pharmacol; 1998 May; 54(3):203-8. PubMed ID: 9681660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reasons for the under-use of secondary prevention therapies in coronary patients over the age of 70 years].
    Cournot M; Cambou JP; Quentzel S; Danchin N
    Ann Cardiol Angeiol (Paris); 2005 Dec; 54 Suppl 1():S17-23. PubMed ID: 16411647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening and management of coronary artery disease in diabetic patients].
    Kraiem S; Abassi C; Annabi N; Smaali I; Issaa I; Wali M; Malou M; Hannachi S; Longo S; Battikh K; Slimane ML
    Tunis Med; 2006 Oct; 84(10):670-6. PubMed ID: 17193866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary prevention therapies for coronary heart disease in patients with type 2 diabetes: an audit.
    Sharma KK; Guptha S; Gupta R
    J Assoc Physicians India; 2012 Apr; 60():28-30. PubMed ID: 23029739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
    Yahia DH; Pereg D; Lishner M; Elis A
    Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.